Name | 3-[2-(4-methylsulfinylphenyl)ethenyl]-1,2,4-oxadiazole |
---|---|
Synonyms |
1,2,4-Oxadiazole,3-[(1E)-2-[4-(methylsulfinyl)phenyl]ethenyl]
BTI 2286E 3-p-methylsulfinylstyryl-1,2,4-oxadiazole 3-(trans-4-methanesulfinyl-styryl)-[1,2,4]oxadiazole trans-3-p-Methylsulfinylstyryl-1,2,4-oxadiazol 3-(4-Methylsulfinylstyryl)-1,2,4-oxadiazole 1,2,4-Oxadiazole,3-[2-[4-(methylsulfinyl)phenyl]ethenyl]-,(E) 1,2,4-Oxadiazole,2-[p-(methylsulfinyl)styryl]-,(E)-(8CI) |
Density | 1.37g/cm3 |
---|---|
Boiling Point | 453.482ºC at 760 mmHg |
Molecular Formula | C11H10N2O2S |
Molecular Weight | 234.27400 |
Flash Point | 228.058ºC |
Exact Mass | 234.04600 |
PSA | 75.20000 |
LogP | 2.84310 |
Vapour Pressure | 0mmHg at 25°C |
Index of Refraction | 1.648 |
HS Code | 2934999090 |
---|
~95% 24664-13-9 |
Literature: Glaxo Laboratories Limited Patent: US4012377 A1, 1977 ; |
Precursor 1 | |
---|---|
DownStream 0 |
HS Code | 2934999090 |
---|---|
Summary | 2934999090. other heterocyclic compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |